BioTech Social Media and Updates

Monocyte IL‑10 Explains Sex Differences in Pain Duration
SocialFeb 20, 2026

Monocyte IL‑10 Explains Sex Differences in Pain Duration

Sex differences in pain duration Finding interleukin-10 from monocytes as an/the explanation (in the experimental model and people) @SciImmunology https://t.co/fOsciwav7Y

By Eric Topol
FDA Cracks Down as Novo Sues Hims over Semaglutide
SocialFeb 20, 2026

FDA Cracks Down as Novo Sues Hims over Semaglutide

This is the first reference which I heard directly from FDA commissioner Dr. Marty Makary regarding $HIMS, $NVO 🧵👇and the recent legal actions that the HHS had initiated against HIMs and Hers. When he was asked by @annikakimc - @CNBC’s...

By Yair Einhorn
Nasal Mucosa Targeted for Universal Respiratory Vaccine
SocialFeb 20, 2026

Nasal Mucosa Targeted for Universal Respiratory Vaccine

How to get a universal vaccine vs respiratory threats? Block via the nasal mucosa @ScienceMagazine https://t.co/IjCkbF05LB @NatRevImmunol https://t.co/2W7SZ1fHSR https://t.co/XcEzcMeXrB

By Eric Topol
New Drug Discoveries Target Cancer and Autoimmunity
SocialFeb 20, 2026

New Drug Discoveries Target Cancer and Autoimmunity

Discovering Drugs for Cancer and Autoimmunity. Listen to @Satpathology on The Long Run podcast. Sponsored by @AlphaSenseInc Dash Bio. https://t.co/02keVFdqzj

By Luke Timmerman
Lymphopenia Reversal Won’t Secure Anktiva FDA Approval
SocialFeb 20, 2026

Lymphopenia Reversal Won’t Secure Anktiva FDA Approval

Reversal of lymphopenia is not an acceptable endpoint for Anktiva FDA approval. $IBRX could file but if it did, the application would be rejected.

By Adam Feuerstein
Cyborg Islet-Cell Implant Boosts Precision Diabetes Therapy
SocialFeb 20, 2026

Cyborg Islet-Cell Implant Boosts Precision Diabetes Therapy

A cyborg pancreatic islet-cell implant takes the stem cell strategy to a new level of precision and potential future therapy for T1 diabetes @ScienceMagazine https://t.co/gkmsrzU1e4 https://t.co/qgegRPlEIl

By Eric Topol
Neutrophil Phenotypes and Spatial Patterns Mapped in Colorectal Cancer
SocialFeb 20, 2026

Neutrophil Phenotypes and Spatial Patterns Mapped in Colorectal Cancer

Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in colorectal cancer https://t.co/0FLusa7vuB https://t.co/8MswWoLhCa

By Ming Tang
Screening Cuts Advanced Colon Cancer, Boosts Early Detection
SocialFeb 20, 2026

Screening Cuts Advanced Colon Cancer, Boosts Early Detection

Screening works for colon cancer. Largest trial ever done. Today @NatureMedicine A randomized trial of colon cancer screening by colonoscopy or occult blood (FIT) vs control in nearly 280,000 participants showed signficantly more early diagnosis (stage I-II) and less stage...

By Eric Topol
Exercise‑induced Liver Enzyme GPLD1 Restores Memory, Boosts Vascular Health
SocialFeb 20, 2026

Exercise‑induced Liver Enzyme GPLD1 Restores Memory, Boosts Vascular Health

Liver enzyme GPLD1 produced during exercise reverses aging- and Alzheimer’s-related memory loss by improving vascular health https://www.cell.com/cell/fulltext/S0092-8674%2826%2900111-X

By David Sinclair
NKTR’s Alopecia Areata Play: Market Misprices Massive Upside
SocialFeb 20, 2026

NKTR’s Alopecia Areata Play: Market Misprices Massive Upside

Ok, so I have finally gotten around to writing out my updated thoughts/thesis on $NKTR. Link in this post. I'm about as bullish on the stock now as I've ever been. The document is very long (sorry, but it's free...give me...

By Adam May
AZN's Calquence + Venetoclax Approved for CLL Treatment
SocialFeb 20, 2026

AZN's Calquence + Venetoclax Approved for CLL Treatment

#AZN Calquence combined with Venetoclax approved in US for treating Adults with Chronic Lymphocytic Leukaemia in a particular form.

By WheelieDealer
Galleri Test Misses Primary Goal, Shows Secondary Promise
SocialFeb 19, 2026

Galleri Test Misses Primary Goal, Shows Secondary Promise

A key study of $GRAL's Galleri test in the UK failed to reach its primary endpoint, but showed benefits on a secondary endpoint. Tell me what you all think. https://t.co/CDrvokqPop

By Matthew Herper
Examining Vaccine Development Amid America's Science‑Anti‑Science Divide
SocialFeb 19, 2026

Examining Vaccine Development Amid America's Science‑Anti‑Science Divide

Many thanks to Freedom Together Foundation medical research consortium for hosting my remarks this week ⁦@RockefellerUniv⁩ discussing our vaccine development program and my work on the history of medical science vs anti-science in America https://t.co/etbLqiezEA

By Peter Hotez
EBV DNA Linked to Multiple Autoimmune Diseases in 800k Genomes
SocialFeb 19, 2026

EBV DNA Linked to Multiple Autoimmune Diseases in 800k Genomes

🆕@Nature Genome sequencing of >800,000 people finds Epstein-Barr virus reads and their association with other autoimmune diseases besides multiple sclerosis, including type 1 diabetes, inflammatory bowel disease, and hypothyroidism https://t.co/FKCV4OInT5

By Eric Topol
Altesa Secures $75M for Lung Drug, Led by Ex‑Trump Official
SocialFeb 19, 2026

Altesa Secures $75M for Lung Drug, Led by Ex‑Trump Official

Altesa, run by former Trump official, raises $75M for well-traveled lung drug https://t.co/bUx5dcvNJy by @gwendolynawu #biotech #startups

By Ben Fidler
New Drug Development Reforms Aim to Match China
SocialFeb 19, 2026

New Drug Development Reforms Aim to Match China

These proposed reforms to pre-clinical drug development and to smoothing the transition to first-in-human studies could be the most consequential steps toward leveling the playing field with China. https://t.co/oVY6N3xo9Y

By Scott Gottlieb
Adding Fragmentomics Boosts GRAIL’s Multicancer Detection Accuracy
SocialFeb 19, 2026

Adding Fragmentomics Boosts GRAIL’s Multicancer Detection Accuracy

The most used multicancer early detection (MCED) blood test (liquid biopsy) uses methylation (GRAIL). But combining that with DNA fragmentomics, as reported today @NatureCancer, improves early detection https://t.co/VkNDR4XuW3

By Eric Topol
FDA Proposes Single Pivotal Trial as Approval Standard
SocialFeb 19, 2026

FDA Proposes Single Pivotal Trial as Approval Standard

FDA leaders say one pivotal trial, not two, should be ‘default’ for drug approvals https://t.co/ADRb1miphf by Kristin Jensen #biotech

By Ben Fidler
Group 3 Medulloblastoma Shows Diverse Lipid Dependencies
SocialFeb 19, 2026

Group 3 Medulloblastoma Shows Diverse Lipid Dependencies

Multiomic integration reveals tumoral heterogeneity of lipid dependence within lethal group 3 medulloblastoma https://t.co/tpjJiRa08t https://t.co/z7aIYerTqO

By Ming Tang
Intronic Reads in Bulk RNA‑seq: Common and Multi‑Faceted
SocialFeb 19, 2026

Intronic Reads in Bulk RNA‑seq: Common and Multi‑Faceted

Why are there intronic reads in your bulk RNA-seq data? You're not alone—it's common, and the reasons are more layered than you think. Let’s break it down. 🧵 https://t.co/SNJnohqHUM

By Ming Tang
Former Psilocybin Trial Participant Shocked by New Findings
SocialFeb 19, 2026

Former Psilocybin Trial Participant Shocked by New Findings

"I took part in a 2012 psilocybin trial. What I’m seeing now horrifies me" https://t.co/T1BLv6n59X via @statnews

By Matthew Herper
Blood P‑tau217 Test Predicts Alzheimer’s Symptoms 20 Years Ahead
SocialFeb 19, 2026

Blood P‑tau217 Test Predicts Alzheimer’s Symptoms 20 Years Ahead

Predicting when symptoms of Alzheimer's disease will occur with elevated p-tau217 blood test and a person's age, even 20+ years in advance @NatureMedicine https://t.co/EYaGglBh1H

By Eric Topol
Gossamer Lung Trial and ProMis Alzheimer Therapy Spotlight
SocialFeb 19, 2026

Gossamer Lung Trial and ProMis Alzheimer Therapy Spotlight

This week's Biotech Scorecard newsletter: -- What to expect from $GOSS Gossamer Bio’s late-stage lung disease study -- A better, safer Alzheimer’s treatment? ProMis $PMN takes its shot https://t.co/YaA8kvUR4Z

By Adam Feuerstein
Profusa Enables Real‑Time Tissue Biochemistry Monitoring
SocialFeb 19, 2026

Profusa Enables Real‑Time Tissue Biochemistry Monitoring

👍Profusa is my pick for 2026. Fascinating technology to measure real time tissue biochemistry. This is a fundamental shift from blood to tissue to shine a new light on cellular status and metabolism. https://t.co/gfduGvgJTX @ProfusaInc #medicine $PFSA #diabetes

By John Nosta
INSM Projects 2026 Brinsupri Sales Minimum $1B
SocialFeb 19, 2026

INSM Projects 2026 Brinsupri Sales Minimum $1B

$INSM guides to 2026 Brinsupri sales of "at least $1B" in line with consensus. https://t.co/o7JhPKU3m1

By Adam Feuerstein
Shape‑conformal 3D Frameworks Enable Full‑surface Neural Organoid Electrophysiology
SocialFeb 19, 2026

Shape‑conformal 3D Frameworks Enable Full‑surface Neural Organoid Electrophysiology

If you’re interested in organoid biology and/or 3D bioelectronics, then check out our paper published today in Nature Biomedical Engineering, titled ‘Shape-conformal porous frameworks for full coverage of neural organoids and high-resolution electrophysiology,’ at https://t.co/Y7MzvRQKTm.  This work introduces a technology...

By John A. Rogers
Reversing Nerve Cell Age to Combat ALS, Alzheimer’s
SocialFeb 19, 2026

Reversing Nerve Cell Age to Combat ALS, Alzheimer’s

Super proud of Dr. Kelly Rich, senior postdoc in our lab who's pioneering nerve cell epigenetic age reversal to treat diseases such as ALS and Alzheimer's 🪨⭐️ https://open.spotify.com/episode/7nWkEH5li36oW9monEIG8B

By David Sinclair
US Vaccine Policy Shift Boosts MRNA Stock Appeal
SocialFeb 18, 2026

US Vaccine Policy Shift Boosts MRNA Stock Appeal

Macro: US vaccine-policy swing heightens regulatory risk; FDA will review Moderna’s flu shot. Key: public dispute, amended filing; decision by Aug 5. Risk: political oversight. Trade: Buy MRNA. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
AI Automates Cytology, Streamlining Cell Pre‑Screening
SocialFeb 18, 2026

AI Automates Cytology, Streamlining Cell Pre‑Screening

AI automates cytology, which is a laborious, manual, human subjective task, for pre=screening cells for abnormalities and making initial diagnoses today @Nature https://t.co/ZI3F2pkMxE https://t.co/WsUcRjkHFN https://t.co/mdz1DM6xs7

By Eric Topol
Finalizing Top 100 Biotech VCs, Join 2026 Webinar
SocialFeb 18, 2026

Finalizing Top 100 Biotech VCs, Join 2026 Webinar

We're wrapping up the fact checking process for our annual Top 100 biotech VCs list and prepping for our companion webinar on VC investing in 2026. If this is a topic near and dear to your heart, be sure to...

By John Carroll
Conversational AI Unlocks Hidden Value in Scientific Literature
SocialFeb 18, 2026

Conversational AI Unlocks Hidden Value in Scientific Literature

So cool to see the focus on really mining the scientific literature from @EdisonSci — it’s where a ton of valuable information is waiting and having models conversant in it is a big deal 👏👏👏

By Jason Kelly
Brain’s Venous Sinuses Patrol Immune Cells and Drain Fluid
SocialFeb 18, 2026

Brain’s Venous Sinuses Patrol Immune Cells and Drain Fluid

What's ruffling? Large veins interfacing the skull (venous sinuses) that patrol immune cells and help drain the brain https://t.co/WsML3Jd1yA

By Eric Topol
FDA Chief: Most Drugs Belong Over‑the‑counter
SocialFeb 18, 2026

FDA Chief: Most Drugs Belong Over‑the‑counter

FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive https://t.co/HiYBuxvyWC

By Matthew Herper
Federal Vaccine Panel Meeting Delayed After HHS Missed Deadlines
SocialFeb 18, 2026

Federal Vaccine Panel Meeting Delayed After HHS Missed Deadlines

Upcoming meeting of federal vaccine panel may be postponed after HHS missed deadlines https://t.co/zfAl7owoQg via @statnews

By Matthew Herper
MRNA Vaccines Advance Triple‑negative Breast Cancer Therapy
SocialFeb 18, 2026

MRNA Vaccines Advance Triple‑negative Breast Cancer Therapy

The unfounded move by @HHSGov against mRNA vaccines will hurt our future potent immune therapy vs cancer. Another point of progress for triple-negative breast cancer with individualized neoantigen mRNA vaccines today @Nature Adds to successful pancreatic, renal cell, melanoma reports...

By Eric Topol
Listen to Biology’s Early Whispers to Prevent Disease
SocialFeb 18, 2026

Listen to Biology’s Early Whispers to Prevent Disease

We could prevent diseases so much better but we haven't learned to listen to when biology whispers long (10 + years) in advance. A key theme in Super Agers, too. https://t.co/0pSap3f32N @NathanPriceSci @ @nrappapo @BuckInstitute example below for Type 2...

By Eric Topol
Agentic AI Enables Accurate Rare Disease Diagnosis via DeepRare
SocialFeb 18, 2026

Agentic AI Enables Accurate Rare Disease Diagnosis via DeepRare

Another good use case for agentic AI in medicine: diagnosis of rare diseases. Exemplified by DeepRare https://t.co/XBd68V3iDl https://t.co/rBl5yn95sI

By Eric Topol
Pharma Demands FDA Stability as Leadership Sparks Drama
SocialFeb 18, 2026

Pharma Demands FDA Stability as Leadership Sparks Drama

The pharmaceutical industry needs stability & clear guidance from #FDA as it attempts to bring through licensure new drugs & vaccines. Vinay Prasad, FDA's head of biologics, has brought drama to a setting where it's not welcome, @matthewherper.bsky.social writes. https://t.co/Qaw1QmYNpL

By Helen Branswell
FDA's Erratic, Unpredictable Decisions Undermine Drug Regulation
SocialFeb 18, 2026

FDA's Erratic, Unpredictable Decisions Undermine Drug Regulation

The FDA keeps spinning, spinning, spinning round and round. Just what you want from a drug regulator: Erratic decision-making and complete unpredictability. https://t.co/q5abiPwgkW

By John Carroll
V‑plot TF Binding May Be Artifact of Fragmentation
SocialFeb 18, 2026

V‑plot TF Binding May Be Artifact of Fragmentation

🧵 That V-plot showing transcription factor binding? It might be an artifact. New research shows chromatin fragmentation methods create patterns even on naked DNA. Here's what went wrong. https://t.co/79B5c0ulgD

By Ming Tang
Claude Code Fabricates Fake ENSEMBL IDs for Gene Plots
SocialFeb 18, 2026

Claude Code Fabricates Fake ENSEMBL IDs for Gene Plots

1/ Claude Code just hallucinated ENSEMBL IDs for my volcano plot. (it happened last week for real) I asked it to highlight specific genes. The data matrix uses ENSEMBL identifiers. Instead of flagging that it couldn't map the gene symbols, it invented...

By Ming Tang
10 Free Bioinformatics Tools to Save Time & Money
SocialFeb 18, 2026

10 Free Bioinformatics Tools to Save Time & Money

🧵 10 free bioinformatics tools you should know in 2026. These will save you time, money, and headaches. https://t.co/t8amdLE4MX

By Ming Tang
FDA's Moderna U‑turn Highlights Agency Chaos
SocialFeb 18, 2026

FDA's Moderna U‑turn Highlights Agency Chaos

The FDA’s Moderna $MRNA pirouette is one more sign of chaos at the agency https://t.co/zThJqhT2BS via @matthewherper

By Adam Feuerstein
FDA Relents, Agrees to Review Moderna's mRNA Flu Vaccine
SocialFeb 18, 2026

FDA Relents, Agrees to Review Moderna's mRNA Flu Vaccine

#FDA backs down on #Moderna: The agency had refused to review the company's licensure application for an mRNA flu vaccine, but after significant pushback has relented. https://t.co/omo7bEBQGW

By Helen Branswell
Moderna's Flu Vaccine Review Set for August 5
SocialFeb 18, 2026

Moderna's Flu Vaccine Review Set for August 5

$MRNA says FDA will now review its flu vaccine. PDUFA date is Aug. 5. https://t.co/npZzeEa5nk

By Adam Feuerstein
FDA Splits Moderna Flu Vaccine Review by Age
SocialFeb 18, 2026

FDA Splits Moderna Flu Vaccine Review by Age

FDA agrees to review Moderna flu vaccine application, splitting review into standard approval for those under 65 and accelerated approval for those 65 and above. $mrna https://t.co/HMMlPm0PGh

By Matthew Herper
AI Transforms Unknown Genetic Variants Into Actionable Insights
SocialFeb 18, 2026

AI Transforms Unknown Genetic Variants Into Actionable Insights

A “Variant of Unknown Significance” is a genetic finding that can’t yet be interpreted, leaving families with uncertainty instead of answers. Now, AI agents can help connect sequencing data with scientific literature and biological context to turn VUS into traceable, evidence-backed...

By Catherine Adenle
Resveratrol Activates SIRT1 to Shield Kidneys From Fat
SocialFeb 18, 2026

Resveratrol Activates SIRT1 to Shield Kidneys From Fat

Resveratrol protects kidneys from fat accumulation and diabetic kidney disease by activating SIRT1, similar to its effects on fatty liver 🐁 www.sciencedirect.com/science/article/abs/pii/S1098882326000067

By David Sinclair
PRC2 Links Embryonic Methylation to Age Reversal
SocialFeb 17, 2026

PRC2 Links Embryonic Methylation to Age Reversal

Embryos and old people have a lot in common: the PRC2 protein complex, which controls DNA methylation during embryogenesis, is a key participant in age reversal via epigenetic reprogramming link.springer.com/content/pdf/10.1038/s44320-026-00195-9.pdf

By David Sinclair